Images
The newspapers El País and ABC, among other media, have echoed on the last Barcelona Biomed Conference, called “Immunotherapy beyond cancer. A cure for age-related diseases”, which was held from 18 to 20 November. “Immunotherapy is still very experimental, but we believe that in the future it could be beneficial for the treatment of diseases such as Alzheimer’s, Parkinson’s and pulmonary and renal fibrosis,” says Manuel Serrano, ICREA researcher at IRB Barcelona and co-organiser of the conference together with the scientist Guido Kroemer, from the Centre de Recherche des Cordeliers (Paris). As in previous events, this conference was organised by IRB Barcelona with the support of the BBVA Foundation.
Link to El País
Link to ABC
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
